Cargando…

KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection

Killer cell immunoglobulin-like receptors (KIRs) influence both innate and adaptive immunity. But while the role of KIRs in NK-mediated innate immunity is well-documented, the impact of KIRs on the T cell response in human disease is not known. Here we test the hypothesis that an individual's K...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seich al Basatena, Nafisa-Katrin, MacNamara, Aidan, Vine, Alison M., Thio, Chloe L., Astemborski, Jacquie, Usuku, Koichiro, Osame, Mitsuhiro, Kirk, Gregory D., Donfield, Sharyne M., Goedert, James J., Bangham, Charles R.M., Carrington, Mary, Khakoo, Salim I., Asquith, Becca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192839/ https://www.ncbi.nlm.nih.gov/pubmed/22022261 http://dx.doi.org/10.1371/journal.ppat.1002270

Ejemplares similares

Frequency and function of KIR(+) CD8(+) T cells in HTLV-1 infection
por: Twigger, Katie, et al.
Publicado: (2014)

Identifying the immune interactions underlying HLA class I disease associations
por: Debebe, Bisrat J, et al.
Publicado: (2020)

The Efficiency of the Human CD8+ T Cell Response: How Should We Quantify It, What Determines It, and Does It Matter?
por: Elemans, Marjet, et al.
Publicado: (2012)

Why Don't CD8+ T Cells Reduce the Lifespan of SIV-Infected Cells In Vivo?
por: Elemans, Marjet, et al.
Publicado: (2011)

Can Non-lytic CD8+ T Cells Drive HIV-1 Escape?
por: Seich al Basatena, Nafisa-Katrin, et al.
Publicado: (2013)

Peptide selectivity discriminates NK cells from KIR2DL2‐ and KIR2DL3‐positive individuals
por: Cassidy, Sorcha, et al.
Publicado: (2014)

KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
por: Tapsoba, Aziz Sidi Aristide, et al.
Publicado: (2022)

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC
por: Lisovsky, Irene, et al.
Publicado: (2019)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells
por: Sim, Malcolm J. W., et al.
Publicado: (2015)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
por: Morales, Raquel, et al.
Publicado: (2023)

Two New Cases of KIR3DP1, KIR2DL4-Negative Genotypes, One of which is also Lacking KIR3DL2
por: Niepiekło-Miniewska, Wanda, et al.
Publicado: (2014)

Genetic Control of Variegated KIR Gene Expression: Polymorphisms of the Bi-Directional KIR3DL1 Promoter Are Associated with Distinct Frequencies of Gene Expression
por: Li, Hongchuan, et al.
Publicado: (2008)

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
por: Moradi, Shoeib, et al.
Publicado: (2021)

T-Cell Epitope Prediction: Rescaling Can Mask Biological Variation between MHC Molecules
por: MacNamara, Aidan, et al.
Publicado: (2009)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
por: Chrul, Slawomir, et al.
Publicado: (2006)

A novel antibody combination to identify KIR2DS2(high) natural killer cells in KIR2DL3/L2/S2 heterozygous donors
por: Blunt, Matthew D., et al.
Publicado: (2019)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

Clinical Impact of KIR2DS3 and KIR2DL3 Genes in Neuroblastoma Patients
por: Sezgin, Gülay, et al.
Publicado: (2022)

Estimating rates of de novo infection and mitotic replication in HTLV-1 persistence: de novo infection continues after early infection
por: Laydon, Daniel J, et al.
Publicado: (2015)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

A novel full‐length two‐domain KIR2DL5A allele isolated in Zimbabwean samples: KIR2DL5A*0010104
por: van Pul, Lisa, et al.
Publicado: (2020)

HIV-1 p24 derived epitopes modulate KIR2DL2-binding to HLA-Cw03
por: van Teijlingen, NH, et al.
Publicado: (2012)

Regulation of KIR3DL3 Expression via miRNA
por: Nutalai, Rungtiwa, et al.
Publicado: (2019)

Innate receptors modulating adaptive T cell responses: KIR-HLA interactions and T cell-mediated control of chronic viral infections
por: Mora-Bitria, Laura, et al.
Publicado: (2023)

KIR/HLA Interactions and Pathogen Immunity
por: Jamil, Khaleel M., et al.
Publicado: (2011)

KIR and HLA haplotype analysis in a family lacking the KIR 2DL1-2DP1 genes
por: Vojvodić, S, et al.
Publicado: (2015)

KIR2DL2/S2 and KIR2DS5 in alcoholic cirrhotic patients undergoing liver transplantation
por: Legaz, Isabel, et al.
Publicado: (2019)

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
por: Thomas, David L., et al.
Publicado: (2009)

Enrichment of Variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU Patients: An Exploratory Study
por: La, David, et al.
Publicado: (2011)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
por: Euchner, Johanna, et al.
Publicado: (2021)

In vitro education of human natural killer cells by KIR3DL1
por: Pugh, Jason, et al.
Publicado: (2019)

The KIR2DL1 intermediate upstream element participates in gene activation
por: Wright, Paul W., et al.
Publicado: (2023)

KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles
por: Bari, Rafijul, et al.
Publicado: (2016)

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
por: Erbe, Amy K., et al.
Publicado: (2019)

异基因造血干细胞移植中非血缘供者KIR2DL1、KIR3DL1免疫重建规律的研究
Publicado: (2017)

Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma
por: Muriuki, Beatrice M., et al.
Publicado: (2023)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
por: Hirayasu, Kouyuki, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_b6ufhtk31o77i54i5d9bfrp8ad